Strifon Forte Dsc

ANDA 81008, held by Ferndale Labs. Chlorzoxazone.

As of Nov 15, 2026, ANDA 81008 (Strifon Forte Dsc), held by Ferndale Labs, was first approved by FDA on Dec 23, 1988, with 3 approved supplements and 0 published complete response letters.

First approved: Dec 23, 1988
Supplements approved: 3
Complete response letters: 0

Approvals and New Uses

The original application and every efficacy supplement, newest first; all 4 submissions below

Date	Submission	Status	Documents
Dec 23, 1988	Original application	Approved	None posted

Products

1 strengths and forms

Product	Active ingredient	Marketing
Strifon Forte Dsc500MG · tablet;oral	Chlorzoxazone	Discontinued

All 4 submissions, including labeling and manufacturing supplements


Nov 20, 1991	Supplement 1Manufacturing	Approved	None posted
Nov 20, 1991	Supplement 2Manufacturing	Approved	None posted
Nov 20, 1991	Supplement 3Labeling	Approved	None posted
Dec 23, 1988	Original application	Approved	None posted

Identifiers

Application: ANDA 81008
Drugs@FDA: Overview at FDA
Company: Ferndale Laboratories

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters